D-penicillamine treatment of hyperbilirubinaemia in preterm infants.
In 41 hyperbilirubinaemic infants born before the 38th gestational week intravenous D-penicillamine treatment was applied in doses of 300 mg/kg body weight/day. As compared to 41 infants of identical gestational age and treated under identical circumstances, penicillamine ensured favourable results, especially in babies born after the 33rd gestational week. Some undesirable side-effects have to be taken into account, but they are infrequent if the indication is correct.
D005078:Exchange Transfusion, Whole Blood; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000628:therapy*; D007567:Jaundice, Neonatal / Q000628:therapy*; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage / Q000627:therapeutic use*; D010789:Phototherapy
D010396:Penicillamine